NEPH
Nephros Inc
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 4.38
Buy <=wait / entry
USD 3.83
Trim >=take some off
USD 5.50
Thesis breakThe thesis would be invalidated by a sustained deceleration in year-on-year reve...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 17% | 100 / 100 | 17.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 34% | 10 / 100 | 3.4 |
| Weighted conviction | 51 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Record Q2 2026 net revenue of $6.0 million, up 36% YoY with core programmatic revenue growing 27% YoY
- Net income rose to $1.2 million including approximately $0.6 million one-time tariff refund benefit
- Gross margin improvement reported alongside revenue growth